CPSC Recall in 2022: Mohnark Pharmaceuticals Recalls Lidocaine Topical Anesthetic Cream Due to Failure to Meet Child-Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)

Updated on March 25, 2026.

See the recall details below. You can also see similar information for other consumer product recalls in 2022.

Data Source: CPSC.

Recall Number: 22-754

Date: June 30, 2022

Product Name: Lidocaine 4% Topical Anesthetic Cream

Recall Description:

The recall involves Mohnark Pharmaceuticals Lidocaine 4% Topical Anesthetic Cream. The product was sold in a white tube with a flip-top closure. Mohnark Pharmaceuticals is printed under the blue and green logo on the right side of the product tube. The lot code is located at the bottom of the product tube. The affected lot codes are 01202201, 210201, 210301, 210503, 210505, 210601, 211002 and 210401. The UPC 860002324906 is located on bottom side panel of the packaging.

Hazard Description:

The product contains lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging is not child resistant, posing a risk of poisoning to young children if they ingest the anesthetic cream.

Consumer Action:

Remedy Type:

Dispose

Units: About 9,000

Incidents:

None reported

Sold At:

Online at Amazon.com and Walmart.com from January 2021 through January 2022 for about $7.

Manufactured In:

United States